MoonLake Immunotherapeutics (MLTX) Depreciation and Depletion (2021 - 2024)
MoonLake Immunotherapeutics (MLTX) recorded quarterly Depreciation and Depletion of $32515.0 in Q3 2024, up 15.66% quarter-over-quarter from $28112.0 in Q2 2024, and up 888.3% on a YoY basis from $3290.0 in Q4 2023.
MoonLake Immunotherapeutics (MLTX) Depreciation and Depletion (2021 - 2024) Analysis & Trends
MoonLake Immunotherapeutics' Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $32515.0 for Q3 2024.
- In Q3 2024, Depreciation and Depletion rose 888.3% year-over-year to $32515.0; the TTM figure through Sep 2024 stood at $86729.0 (up 559.14% YoY), while the FY2023 annual figure was $13158.0, up 6.47% from the prior year.
- Depreciation and Depletion was $32515.0 for Q3 2024 at MoonLake Immunotherapeutics, up from $28112.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $32515.0 in Q3 2024 to a low of $2271.0 in Q3 2021.
- Historically, Depreciation and Depletion has averaged $8938.3 across 4 years, with a median of $3290.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Depreciation and Depletion sank 33.84% in 2022, then soared 888.3% in 2024.
- A 4-year view of Depreciation and Depletion shows it stood at $4971.0 in 2021, then plunged by 33.84% to $3289.0 in 2022, then changed by 0.0% to $3289.0 in 2023, then surged by 888.6% to $32515.0 in 2024.
- The last three Depreciation and Depletion figures came in at $32515.0 (Q3 2024), $28112.0 (Q2 2024), and $22813.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 32,515.00 |
| Sep 30, 2024 | 32,515.00 |
| Jun 30, 2024 | 28,112.00 |
| Jun 30, 2024 | 28,112.00 |
| Mar 31, 2024 | 22,813.00 |
| Mar 31, 2024 | 22,813.00 |
| Dec 31, 2023 | 3,289.00 |
| Dec 31, 2023 | 3,289.00 |
| Sep 30, 2023 | 3,290.00 |
| Sep 30, 2023 | 3,290.00 |
| Jun 30, 2023 | 3,289.00 |
| Jun 30, 2023 | 3,289.00 |
| Mar 31, 2023 | 3,290.00 |
| Mar 31, 2023 | 3,290.00 |
| Dec 31, 2022 | 3,289.00 |
| Dec 31, 2022 | 3,289.00 |
| Sep 30, 2022 | 3,293.00 |
| Sep 30, 2022 | 3,293.00 |
| Jun 30, 2022 | 3,288.00 |
| Jun 30, 2022 | 3,288.00 |